TTK Healthcare (TTKHLTCARE) | Stock Overview & Key Data
TTK Healthcare Performance Comparison
Stock Range
Today's Range
Low: ₹1,136.90
High: ₹1,154.00
on August 12, 2025
52 Week Range
Low: ₹1,101.05
High: ₹1,893.95
on March 17, 2025
on September 10, 2024
All-Time High: ₹1,893.95 on September 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR16.3B
EPS
44.64
P/E Ratio (TTM)
25.54
Forward P/E
N/A
P/B Ratio
1.51
PEG Ratio
0.85
Div. Yield
0.74%
ROE
7.67%
Beta
0.301
Debt to Equity
2.27
Financial Highlights
Profitability
Gross Margin
55.03%
Operating Margin
0.22%
Profit Margin
7.69%
Returns and Earnings
Return on Assets (TTM)
6.37%
Return on Equity (TTM)
7.67%
EBITDA
INR1.0B
Net Income (TTM)
INR630.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR580.33
Quarterly Revenue Growth (YoY)
8.90%
Quarterly Earnings Growth (YoY)
-58.80%
Dividend Information
Last 12-Month Dividend
₹10.00
Current Dividend Yield
0.74%
3-Year Average Dividend Yield
0.85%
3-Year Average Annual Dividend
₹13.33
3-Year Total Dividends
₹40.00
Ex-Dividend Date
July 18, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| TTK Healthcare TTKHLTCARE | 16.27B Small-cap | -6.59% | -13.59% | -6.89% | -7.93% | -19.11% | -28.62% | 35.35% | 126.25% |
| GlaxoSmithKline GLAXO | 455.21B Large-cap | -6.34% | -17.16% | -1.26% | 30.56% | 20.38% | -7.10% | 82.41% | 80.88% |
| Pfizer PFIZER | 228.51B Large-cap | 1.03% | -8.27% | 19.09% | 23.09% | -4.65% | -13.51% | 19.04% | 9.92% |
| Senores SENORES | 30.21B Small-cap | -4.98% | 8.23% | 29.61% | 28.53% | 15.84% | 15.47% | 15.47% | 15.47% |
| Sms Pharmaceuticals SMSPHARMA | 19.90B Small-cap | 0.99% | -3.18% | -6.33% | 14.80% | -10.54% | -21.55% | 184.01% | 144.67% |
| NGL Fine-Chem NGLFINE | 7.66B Small-cap | -4.76% | -6.42% | 9.94% | -3.81% | -32.35% | -48.62% | -22.97% | -34.77% |
Ownership & Short Interest
Insider Ownership
76.64%
Institutional Ownership
2.73%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
7K
Average 90-Day Volume
6K
TTK Healthcare Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in TTK Healthcare would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TTKHLTCARE's 52-week high and low?
- In the last 52 weeks, TTK Healthcare reached a high of ₹1,893.95 (on September 10, 2024) and a low of ₹1,101.05 (on March 17, 2025).
- What is the market cap and P/E ratio for TTKHLTCARE?
- Curious about TTK Healthcare's size and valuation? Its market capitalization stands at 16.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.54, and the forward P/E (looking ahead) is N/A.
- Does TTKHLTCARE pay dividends? If so, what's the yield?
- Yes, TTK Healthcare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.74%, and the company has paid an average of ₹13.33 per share annually over the past 3 years.
- Who are TTK Healthcare's main competitors or similar companies to consider before investing?
When looking at TTK Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO455.21B Healthcare Drug Manufacturers - General -7.10% 82.41% Pfizer
PFIZER228.51B Healthcare Drug Manufacturers - General -13.51% 19.04% Senores
SENORES30.21B Healthcare Drug Manufacturers - General 15.47% 15.47% Sms Pharmaceuticals
SMSPHARMA19.90B Healthcare Drug Manufacturers - General -21.55% 184.01% NGL Fine-Chem
NGLFINE7.66B Healthcare Drug Manufacturers - General -48.62% -22.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for TTK Healthcare Ltd? (e.g., ROE, Debt/Equity)
- To get a sense of TTK Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.67%, the Debt to Equity ratio from the most recent quarter is 2.27, and its Gross Profit Margin stands at 55.03%.
- What is the recent revenue and earnings growth for TTKHLTCARE?
- Looking at TTK Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.90%, and quarterly earnings saw a YoY growth of -58.80%.
- How much of TTKHLTCARE stock is held by insiders and institutions?
- Wondering who owns TTK Healthcare stock? Company insiders (like executives and directors) hold about 76.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.73%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.